• Arrow International (Reading, Pennsylvania) entered into a three-year contract with Novation (Irving, Texas), the supply company of VHA and the University HealthSystem Consortium (UHC), for intra-aortic balloon pumps, balloon catheters and accessories.

• Bayer HealthCare Diagnostics Division (Tarrytown, New York) reported that it has been awarded a single-source award for urine chemistry analyzers and test strips and a dual-source award for urine microscopy from Novation. The award provides VHA and UHC member organizations with access to savings on Bayer Diagnostics’ urine chemistry and urine microscopy products and adds to the four previously established contracts with Novation for automation and immunoassay, hematology, blood gas and molecular products. The three-year pact includes urine chemistry products and reagents for use in the central laboratory and physician office lab settings.

BearingPoint (McLean, Virginia), a management consulting and systems integration firm, said it has won a potential five-year, $15 million contract to provide the Centers for Disease Control and Prevention (CDC; Atlanta) with a wide range of support for its Coordinating Office for Terrorism Preparedness and Emergency Response (COTPER). BearingPoint will provide an array of services to COTPER’s leadership and management team, division of business services and division of state and local readiness.

• Candela (Wayland, Massachusetts) reported that it has signed an exclusive three-year agreement with McKesson Medical-Surgical (San Francisco) for distribution of the company’s aesthetic laser and light-based line of products. The agreement will take effect Nov. 1.

• Cardiac Science (Irvine, California), a manufacturer of automated external defibrillators (AEDs) and provider of AED/CPR training and AED program management services, said it has received orders for 317 Powerheart G3 AEDs to be delivered in this quarter along with AED/CPR training and program management services valued at more than $500,000 from four major military installations in the U.S. The military branches include the U.S. Army 81st Regional Support Command (Birmingham, Alabama); the U.S. Army Corps of Engineers, Louisville District; the Maine National Guard and Fort Hood, Texas, the largest active duty armored post in the country. Along with providing AEDs to the 81st Regional Support Command, Cardiac Science will train more than 2,600 of its personnel at numerous locations in eight states.

• Conceptus (San Carlos, California), developer of the Essure permanent birth control system, reported that Conceptus and Gynecare Worldwide (Somerville, New Jersey), a division of Ethicon, have terminated a co-promotion agreement they entered into in 2003.

• GE Healthcare (Waukesha, Wisconsin) reported that it has signed an agreement with VHA to offer select professional services to VHA member facilities through GE’s Performance Solutions business. The three-year agreement, effective July 1, represents an expansion of an existing relationship. It encompasses operational, business growth and marketing solutions for radiology and education in GE’s change management techniques. GE Healthcare also signed a multi-year agreement with the University of Virginia Health System (UVa; Charlottesville) to develop new, minimally invasive surgery techniques. Using GE Healthcare’s surgical navigation tools, doctors at UVa will research less-invasive methods of therapeutic and surgical intervention for the brain and spine. The parties plan to expand the research to new non-invasive techniques such as image-guided focused ultrasound.

• Innocoll (Ashburn, Virginia) said its Innocoll Technologies subsidiary has entered into a development and distribution agreement with Surgical-IOC (St. Etienne, France) for development of an adhesion barrier product based on Innocoll’s CollaRx technology. Surgical-IOC has exclusive global rights to market and distribute any products derived from the CollaRx technology for the prevention of surgical adhesions, with the exception of North America, Japan and Australasia.

• Medtronic (Minneapolis) said it has entered into a patent cross-licensing agreement with Neuro-Pace (Mountain View, California) a privately held medical device company specializing in the detection, treatment and monitoring of epilepsy and other neurological disorders via responsive brain stimulation. The two companies cross-licensed patents and patent applications of neurological technology related to direct electrical stimulation or monitoring of the brain. Specific terms of the agreement were not disclosed. Medtronic currently is conducting a pivotal clinical trial in the U.S. for the Intercept Epilepsy Control System, the company’s brain stimulation therapy that may reduce seizure rates in epilepsy patients. NeuroPace also is sponsoring a study with its Responsive Neurostimulator system.

• Xilinx (San Jose, California), a supplier of programmable logic, and Siemens Medical Solutions (Malvern, Pennsylvania), entered into a collaboration that is expected to result in what the companies called the “world’s most innovative” 3-D medical imaging solutions. Siemens has selected Xilinx as its FPGA (field programmable gate array) supplier in the development of its next-generation, 3-D image-processing platform, which will be used in future image-processing products.

No Comments